Business
Bionano Announces Presentation of OGM Utility Across Cancer Genomics Research Applications at the American Association for Cancer Research (AACR) Annual Meeting
A sponsored session will feature Dr. Ben Finlay from Sanford Burnham Prebys Institute, Dr. Marc Henri Stern from Institut Curie and Dr. Rashmi
About this update from Bionano Genomics, Inc.
[{"type":"text","content":"A sponsored session will feature Dr. Ben Finlay from Sanford Burnham Prebys Institute, Dr. Marc Henri Stern from Institut Curie and Dr. Rashmi Kanagal-Shamanna from MD Anderson Cancer Center presenting on the utility of optical genome mapping (OGM) across cancer therapy research and development applicationsFive scientific posters will illustrate the application of OGM in cancer research areas including hematological malignancies, homologous recombination deficiency (HRD), and cell manufacturing and bioprocessing quality control SAN DIEGO, April 13, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation in the American Association for Cancer Research (AACR) Annual Meeting 2023 with a broad range of content covering the utility of optical genome mapping (OGM) utility for cell bioprocessing quality control, solid tumor and hematological malignancy cancer research. AACR’s annual meeting brings together industry, medical, and academic professionals to discuss advances in cancer science and medicine. The AACR conference will be held April 14-18, 2023, in Orlando, Florida. As part of a sponsored session, three cancer genomics experts will share their latest research covering the utility of OGM in comprehensive genomic structural variation and homologous recombination deficiency (HRD) analysis of tumor biopsies. The presenters will also discuss their use of OGM for the identification of cancer biomarkers that may be utilized in personal therapy approaches and for drug screening in leukemia research samples. Dr. Ben Finlay of Sanford Burnham Prebys Institute, Dr. Marc Henri Stern from Institut Curie and Dr. Rashmi Kanagal-Shamanna from MD Anderson Cancer Center will present in the Spotlight Theater on Monday, April 17, 2023 at 3:00 pm EST. Poster sessions will be held April 16 from 1:30 pm-5:00 pm, April 17 from 9:00 am- 12:30 pm and 1:30 pm-5:00 pm, and April 18 from 9:00 am-12:30 pm and 1:30 pm-5:00 pm. Poster NumberTitleAuthor240Comprehensive analytical solution to measure HRD genomic scars from pan-cancer NGS panels and optical genome mapping (OGM)Saul D.2074Genome integrity assessment and verification by optical genome mapping for cell manufacturing/bioprocessing applicationsHastie A.2224Applying optical genome mapping to detect genomic biomarkers and use for residual disease monitoring in h...